Gene · 5451
Papers3,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma. | Front Mol Biosci | 2022 | 36310592 | PubTator, text mining | PubMed |
| MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. | Cell Commun Signal | 2022 | 36307841 | PubTator, text mining | PubMed |
| Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers. | Front Oncol | 2022 | 36300092 | PubTator, text mining | PubMed |
| The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment. | Pharmaceuticals (Basel) | 2022 | 36297386 | PubTator, text mining | PubMed |
| miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia. | Medicina (Kaunas) | 2022 | 36295630 | PubTator, text mining | PubMed |
| miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs. | Int J Mol Sci | 2022 | 36293105 | PubTator, text mining | PubMed |
| Clinical Management of Herpes Simplex Virus Keratitis. | Diagnostics (Basel) | 2022 | 36292060 | PubTator, text mining | PubMed |
| Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer's Disease: Do They have a Common Regulating Pathway? | Cells | 2022 | 36291068 | PubTator, text mining | PubMed |
| Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy. | Am J Hum Genet | 2022 | 36243009 | PubTator, text mining | PubMed |
| Epigenetic Modulation of Opioid Receptors by Drugs of Abuse. | Int J Mol Sci | 2022 | 36233105 | PubTator, text mining | PubMed |
| A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies. | Front Genet | 2022 | 36226177 | PubTator, text mining | PubMed |
| Sequence divergence and retrotransposon insertion underlie interspecific epigenetic differences in primates. | Mol Biol Evol | 2022 | 36219870 | PubTator, text mining | PubMed |
| Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes. | Comput Math Methods Med | 2022 | 36213580 | PubTator, text mining | PubMed |
| Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes. | Front Pharmacol | 2022 | 36210832 | PubTator, text mining | PubMed |
| POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity. | Sci Adv | 2022 | 36197978 | PubTator, text mining | PubMed |
| Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting. | Rev Esp Quimioter | 2022 | 36193982 | PubTator, text mining | PubMed |
| Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2022 | 36189286 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study. | Front Endocrinol (Lausanne) | 2022 | 36187128 | PubTator, text mining | PubMed |
| Prediction for optimal dosage of pazopanib under various clinical situations using physiologically based pharmacokinetic modeling. | Front Pharmacol | 2022 | 36172188 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5451/papers?page=17